Half-life-extended Monoclonal Antibody APG777 for Atopic Dermatitis: Design of the Phase 2 APEX Study. J of Skin [Internet]. 2024 Nov. 18 [cited 2025 May 18];8(6):s456. Available from: https://skin.dermsquared.com/skin/article/view/3074